Chrome Extension
WeChat Mini Program
Use on ChatGLM

The First-in-class Bispecific Antibody IBI318 (LY3434172) Targeting PD-1 and PD-L1 in Patients with Advanced Tumors: a Phase Ia/Ib Study

Journal of Hematology & Oncology(2024)

Cited 0|Views3
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined